✦ LIBER ✦

Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats

✍ Scribed by Wang, X.; Zhang, D.; Xu, W.; Liu, H.; Wang, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the novel oral dipeptidyl pept

✍ He, Yan-Ling; Sabo, Ron; Riviere, Gilles-Jacques; Sunkara, Gangadhar; Leon, Sele 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 375 KB

Vildagliptin, a Novel Dipeptidyl Peptida

✍ He, Yan-Ling; Ligueros-Saylan, Monica; Sunkara, Gangadhar; Sabo, Ron; Zhao, Char 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 566 KB

Dose Proportionality and the Effect of F

✍ Sunkara, Gangadhar; Sabo, Ron; Wang, Yibin; He, Yan-Ling; Campestrini, Joelle; R 📂 Article 📅 2007 🏛 Sage Publications 🌐 English ⚖ 154 KB

Pharmacokinetic disposition of anaglipti

✍ Furuta, Shinji; Tamura, Miyuki; Hirooka, Hiroko; Mizuno, Yukie; Miyoshi, Mika; F 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 373 KB

Improved Glucose Tolerance in Zucker Fat

✍ Pederson, R. A.; White, H. A.; Schlenzig, D.; Pauly, R. P.; McIntosh, C. H. S.; 📂 Article 📅 1998 🏛 American Diabetes Association 🌐 English ⚖ 812 KB

Pharmacokinetics and pharmacodynamics of

✍ Kyoung Soo Lim; Joo-Youn Cho; Bo-Hyung Kim; Jung-Ryul Kim; Hwa-Sook Kim; Dong-Ky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB